Piperidine compounds, pharmaceutical composition comprising the same and its use
US-2016362374-A1 · Dec 15, 2016 · US
US2020087256A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020087256-A1 |
| Application number | US-201816618896-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 5, 2018 |
| Priority date | Jun 5, 2017 |
| Publication date | Mar 19, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a new method for preparing a donepezil pamoate (1-benzyl-4-[(5,6-dimethoxyindan-2-one)methyl]piperidine pamoate). The donepezil pamoate prepared by using the method has a high purity and a good flowability.
Opening claim text (preview).
1 . A method for preparing a crystal form A of a compound of formula I, comprising dissolving the compound of formula I in a reaction solvent and adding another solvent dropwise for precipitation to give the crystal form A of the compound of formula I. 2 . The method according to claim 1 , wherein the reaction solvent is one selected from the group consisting of alcohols, ethers, esters, ketones, nitriles, alkanes and water, or a combination thereof. 3 . The method according to claim 1 , wherein the reaction solvent is ketones. 4 . The method according to claim 1 , wherein the reaction solvent is acetone. 5 . The method according to claim 1 , wherein dissolving is carried out at a temperature of from 0 to 50° C. 6 . The method according to claim 1 , wherein dissolving is carried out at a temperature of from 15 to 30° C. 7 . The method according to claim 1 , wherein another solvent is one selected from the group consisting of alcohols, ethers, esters, ketones, nitriles, alkanes and water, or a combination thereof. 8 . The method according to claim 1 , wherein another solvent is water. 9 . The method according to claim 1 , wherein adding another solvent dropwise is carried out at a temperature of 0 to 50° C. 10 . The method according to claim 1 , wherein adding another solvent dropwise is carried out at a temperature of 15 to 30° C.
containing two carboxyl groups both bound to carbon atoms of the condensed ring system · CPC title
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title
by oxygen atoms · CPC title
by change of the physical state, e.g. crystallisation · CPC title
Crystalline forms, e.g. polymorphs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.